Amended Statement of Ownership (sc 13g/a)
March 06 2017 - 11:27AM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
13G
(Rule
13d-102)
INFORMATION
TO BE INCLUDED IN STATEMENTS
FILED
PURSUANT TO §240.13d-1(b), (c) AND (d) AND AMENDMENTS
THERETO
FILED PURSUANT §240.13d-2
(Amendment
No. 2)
CHINA
GEWANG BIOTECHNOLOGY, INC.
(Name
of Issuer)
COMMON
STOCK, $.001 PAR VALUE
(Title
of Class of Securities)
16891W107
(CUSIP
Number)
MAY
16, 2016
(Date
of Event Which Requires Filing of This Statement)
Check the
appropriate box to designate the rule pursuant to which this Schedule is filed:
|
*
|
The remainder of this cover page shall be filled out
for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment
containing information which would alter disclosures provided in a prior cover page.
|
The information
required on the remainder of this cover page shall not be deemed to be "filed" for the purposes of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall
be subject to all other provisions of the Act (however, see the Notes).
|
CUSIP No. 16891W107
|
|
Page 2 of 6
|
|
1.
|
Name
of Reporting Person
HONG KONG NUOXIN INVESTMENT MANAGEMENT CO., LTD.
|
|
2.
|
Check
The Appropriate Box if a Member of a Group
(a) ☐
(b) ☐
|
|
3.
|
SEC
Use Only
|
|
4.
|
Citizenship
or Place of Organization
Hong Kong
|
Number
of
Shares
Beneficially
Owned By
Each
Reporting
Person
With
|
5
.
|
Sole
Voting Power
|
|
|
7,500,000
|
|
6
.
|
Shared
Voting Power
|
|
|
None
|
|
7
.
|
Sole
Dispositive Power
|
|
|
7,500,000
|
|
8
.
|
Shared
Dispositive Power
|
|
|
None
|
|
9
.
|
Aggregate
Amount Beneficially Owned By Each Reporting Person
7,500,000
|
|
10.
|
Check
Box if the Aggregate Amount in Row (9) Excludes Certain Shares
☐
|
|
11.
|
Percent
of Class Represented By Amount in Row (9)
10.0%
|
|
12.
|
Type
of Reporting Person
CO
|
|
CUSIP No. 16891W107
|
|
Page 3 of 6
|
|
1.
|
Name
of Reporting Person
Fanfei Guan
|
|
2.
|
Check
The Appropriate Box if a Member of a Group
(a) ☐
(b) ☐
|
|
3.
|
SEC
Use Only
|
|
4.
|
Citizenship
or Place of Organization
Hong Kong
|
Number
of
Shares
Beneficially
Owned By
Each
Reporting
Person
With
|
5
.
|
Sole
Voting Power
|
|
|
None
|
|
6
.
|
Shared
Voting Power
|
|
|
None
|
|
7
.
|
Sole
Dispositive Power
|
|
|
7,500,000
|
|
8
.
|
Shared
Dispositive Power
|
|
|
None
|
|
9
.
|
Aggregate
Amount Beneficially Owned By Each Reporting Person
7,500,000
|
|
10.
|
Check
Box if the Aggregate Amount in Row (9) Excludes Certain Shares
☐
|
|
11.
|
Percent
of Class Represented By Amount in Row (9)
10.0%
|
|
12.
|
Type
of Reporting Person
IN
|
|
CUSIP No. 16891W107
|
|
Page 4 of 6
|
|
ITEM
|
1(a)
|
NAME
OF ISSUER:
|
|
|
|
|
|
|
|
China
Gewang Biotechnology, Inc.
|
|
|
|
|
|
|
1(b)
|
ADDRESS
OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES:
|
|
|
|
|
|
|
|
Floor
29 No. 334, Huanshi East Road, Yuexiu District
|
|
|
|
Guangzhou
City, Guangdong Province, P.R. China 510623
|
|
|
|
|
|
ITEM
|
2(a)
|
NAME
OF PERSON FILING:
|
|
|
|
|
|
|
|
Hong
Kong Nuoxin Investment Management Co., Ltd.
|
|
|
|
Fanfei
Guan, Director of Hong Kong Nuoxin.
|
|
|
|
|
|
|
2(b)
|
ADDRESS
OF PRINCIPAL OFFICE OR, IF NONE, RESIDENCE:
|
|
|
|
|
|
|
|
The address of the principal business office of Hong Kong Nuoxin Investment Management Co., Ltd. and of Fanfei
Guan is Unit A1, 7/F, Cheuk Nang Plaza, 250 Hennessy Road, Wanchai, Hong Kong.
|
|
|
|
|
|
|
|
|
|
|
2(c)
|
CITIZENSHIP:
|
|
|
|
|
|
|
|
Hong
Kong Nuoxin Investment Management Co., Ltd. was organized in Hong Kong.
|
|
|
|
Fanfei
Guan is a citizen of Hong Kong.
|
|
|
|
|
|
|
2(d)
|
TITLE
OF CLASS OF SECURITIES: Common Stock, $.001 par value
|
|
|
|
|
|
|
2(e)
|
CUSIP
NUMBER: 16891W107
|
|
|
|
|
|
ITEM
|
3
|
IF
THIS STATEMENT IS FILED PURSUANT TO §§240.13d-1(b) OR 240.13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:
|
|
|
|
|
|
|
(a)
|
Broker
or dealer registered under section 15 of the Act (15 U.S.C. 78o).
|
|
|
|
|
|
|
(b)
|
Bank
as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
|
|
|
|
|
|
|
(c)
|
Insurance
company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c)
|
|
|
|
|
|
|
(d)
|
Investment
company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
|
|
|
|
|
|
|
(e)
|
An
investment advisor in accordance with §240.13d-1(b)(1)(ii)(E);
|
|
|
|
|
|
|
(f)
|
An
employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
|
|
|
|
|
|
|
(g)
|
A
parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
|
|
|
|
|
|
|
(h)
|
A
savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
|
|
|
|
|
|
(i)
|
A
church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company
Act of 1940 (15 U.S.C. 80a-3);
|
|
|
|
|
|
|
(j)
|
A
non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J).
|
|
|
|
|
|
|
(k)
|
Group,
in accordance with §240.13d-1(b)(1)(ii)(J).
|
|
CUSIP No. 16891W107
|
|
Page 5 of 6
|
|
ITEM
4.
|
OWNERSHIP.
|
|
|
|
|
The
responses to Items 5 through 11 on the cover page of this filing are incorporated by reference.
|
|
|
|
|
ITEM
5.
|
OWNERSHIP
OF FIVE PERCENT OR LESS OF A CLASS.
|
|
|
|
|
Not Applicable.
|
|
|
|
|
ITEM
6.
|
OWNERSHIP
OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
|
|
|
|
|
Not
Applicable.
|
|
|
|
|
ITEM
7.
|
IDENTIFICATION
AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
|
|
|
|
|
Not
Applicable.
|
|
|
|
|
ITEM
8.
|
IDENTIFICATION
AND CLASSIFICATION OF MEMBERS OF THE GROUP.
|
|
|
|
|
Not
Applicable.
|
|
|
|
|
ITEM
9.
|
NOTICE
OF DISSOLUTION OF GROUP.
|
|
|
|
|
Not
Applicable.
|
|
|
|
|
ITEM 10.
|
CERTIFICATION.
|
|
|
|
|
By
signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and
are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities
and were not acquired and are not held in connection with or as a participation in any transaction having that purpose or
effect, other than activities solely in connection with a nomination under §240.14a-11.
|
|
CUSIP No. 16891W107
|
|
Page 6 of 6
|
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
|
|
Hong
Kong Nuoxin Investment Management Co., Ltd.
|
|
|
|
|
|
Dated:
March 6, 2017
|
By:
|
/s/
Fanfei Guan
|
|
|
|
Fanfei
Guan, Director
|
|
|
|
|
|
|
|
/s/
Fanfei Guan
|
|
|
|
Fanfei
Guan
|
|
|
|
|